scholarly journals Temozolomide therapy for aggressive pituitary Crooke’s cells corticotropinoma causing Cushing’s Disease: A case report with literature review

Author(s):  
Aleksandra Gilis-Januszewska ◽  
Małgorzata Wilusz ◽  
Jacek Pantofliński ◽  
Renata Turek-Jabrocka ◽  
Grzegorz Sokołowski ◽  
...  
2020 ◽  
Vol 0 (1) ◽  
pp. 47-56
Author(s):  
A. V. Solntsava ◽  
N. V. Volkava ◽  
K. A. Beliayeva ◽  
V. A. Zhurauliou

2007 ◽  
Vol 13 (3) ◽  
pp. 296-299 ◽  
Author(s):  
Aasima Yawar ◽  
Lubna Zuberi ◽  
Ñaeemul Haque

HORMONES ◽  
2010 ◽  
Vol 9 (3) ◽  
pp. 269-273 ◽  
Author(s):  
Nikiforos Ballian ◽  
Ioannis I. Androulakis ◽  
Klio Chatzistefanou ◽  
Christianna Samara ◽  
Konstantinos Tsiveriotis ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Yiming Zhao ◽  
Weiwei Liang ◽  
Feng Cai ◽  
Qun Wu ◽  
Yongjian Wang

BackgroundCushing’s disease is associated with an increased risk of pulmonary fungal infection, which could be a relative contraindication for pituitary adenoma excision surgery.CaseWe report a case of a patient with Cushing’s disease and pulmonary Cryptococcus neoformans. A 48-year-old woman was admitted to our hospital because of moon face and edema. Laboratory and radiological findings suggested a diagnosis of Cushing’s disease and pulmonary cryptococcus infection. Fluconazole 400 mg per day was administered intravenously and continued orally for 3 months. Both cryptococcus infection and hypercortisolism relieved and transsphenoidal resection was performed.ConclusionCushing’s disease can be effectively treated with fluconazole to normalize cortisol concentration prior to pituitary surgery. Fluconazole is an alternative treatment especially in Cushing’s disease patients with cryptococcal pneumonia.


2013 ◽  
Vol 59 (5) ◽  
pp. 32-35 ◽  
Author(s):  
N V Dragunova ◽  
Zh E Belaia ◽  
G S Kolesnikova ◽  
L Ia Rozhinskaia

Therapy with bisphosphonates (BP) is recognized to be "the golden standard" for the treatment of osteoporosis of different etiology. However, the data on the use of BP by the women during pregnancy and lactation are scarce. This paper reports a case of gestation, labour, and lactation in a patient treated with ibandronic acid (Bonviva) for severe steroid-induced osteoporosis attributable to Cushing's disease. To our knowledge, the application of ibandronic acid during pregnancy has never been described in the literature before. The present study has demonstrated that therapy with ibandronic acid does not necessarily require the interruption of pregnancy or cessation of birth feeding. Nevertheless, the treatment of the women of reproductive age with BP can be prescribed only upon strict indications.


2020 ◽  
Author(s):  
Yury Anania ◽  
Venteicher S. Andrew ◽  
Pearce M. Thomas ◽  
Gardner A. Paul

Sign in / Sign up

Export Citation Format

Share Document